Literature DB >> 22116936

Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis.

Karim Mesbah1, M Sameer Rana, Alexandre Francou, Karel van Duijvenboden, Virginia E Papaioannou, Antoon F Moorman, Robert G Kelly, Vincent M Christoffels.   

Abstract

The 22q11.2 deletion syndrome (22q11.2DS) is the most common microdeletion disorder and is characterized by abnormal development of the pharyngeal apparatus and heart. Cardiovascular malformations (CVMs) affecting the outflow tract (OFT) are frequently observed in 22q11.2DS and are among the most commonly occurring heart defects. The gene encoding T-box transcription factor 1 (Tbx1) has been identified as a major candidate for 22q11.2DS. However, CVMs are generally considered to have a multigenic basis and single-gene mutations underlying these malformations are rare. The T-box family members Tbx2 and Tbx3 are individually required in regulating aspects of OFT and pharyngeal development. Here, using expression and three-dimensional reconstruction analysis, we show that Tbx1 and Tbx2/Tbx3 are largely uniquely expressed but overlap in the caudal pharyngeal mesoderm during OFT development, suggesting potential combinatorial requirements. Cross-regulation between Tbx1 and Tbx2/Tbx3 was analyzed using mouse genetics and revealed that Tbx1 deficiency affects Tbx2 and Tbx3 expression in neural crest-derived cells and pharyngeal mesoderm, whereas Tbx2 and Tbx3 function redundantly upstream of Tbx1 and Hh ligand expression in pharyngeal endoderm and bone morphogenetic protein- and fibroblast growth factor-signaling in cardiac progenitors. Moreover, in vivo, we show that loss of two of the three genes results in severe pharyngeal hypoplasia and heart tube extension defects. These findings reveal an indispensable T-box gene network governing pharyngeal and OFT development and identify TBX2 and TBX3 as potential modifier genes of the cardiopharyngeal phenotypes found in TBX1-haploinsufficient 22q11.2DS patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116936      PMCID: PMC3491916          DOI: 10.1093/hmg/ddr553

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

1.  Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome.

Authors:  M Bamshad; R C Lin; D J Law; W C Watkins; P A Krakowiak; M E Moore; P Franceschini; R Lala; L B Holmes; T C Gebuhr; B G Bruneau; A Schinzel; J G Seidman; C E Seidman; L B Jorde
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

2.  Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development.

Authors:  D L Chapman; N Garvey; S Hancock; M Alexiou; S I Agulnik; J J Gibson-Brown; J Cebra-Thomas; R J Bollag; L M Silver; V E Papaioannou
Journal:  Dev Dyn       Date:  1996-08       Impact factor: 3.780

3.  Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome.

Authors:  Todd G Davenport; Loydie A Jerome-Majewska; Virginia E Papaioannou
Journal:  Development       Date:  2003-05       Impact factor: 6.868

4.  Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer.

Authors:  Hiroyuki Yamagishi; Jun Maeda; Tonghuan Hu; John McAnally; Simon J Conway; Tsutomu Kume; Erik N Meyers; Chihiro Yamagishi; Deepak Srivastava
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

5.  The del22q11.2 candidate gene Tbx1 regulates branchiomeric myogenesis.

Authors:  Robert G Kelly; Loydie A Jerome-Majewska; Virginia E Papaioannou
Journal:  Hum Mol Genet       Date:  2004-09-22       Impact factor: 6.150

6.  DiGeorge syndrome: part of CATCH 22.

Authors:  D I Wilson; J Burn; P Scambler; J Goodship
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

7.  Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development.

Authors:  Zachary Harrelson; Robert G Kelly; Sarah N Goldin; Jeremy J Gibson-Brown; Roni J Bollag; Lee M Silver; Virginia E Papaioannou
Journal:  Development       Date:  2004-10       Impact factor: 6.868

8.  Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract.

Authors:  Huansheng Xu; Masae Morishima; John N Wylie; Robert J Schwartz; Benoit G Bruneau; Elizabeth A Lindsay; Antonio Baldini
Journal:  Development       Date:  2004-06-02       Impact factor: 6.868

9.  The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart.

Authors:  Willem M H Hoogaars; Alessandra Tessari; Antoon F M Moorman; Piet A J de Boer; Jaco Hagoort; Alexandre T Soufan; Marina Campione; Vincent M Christoffels
Journal:  Cardiovasc Res       Date:  2004-06-01       Impact factor: 10.787

10.  The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo.

Authors:  P H Crossley; G R Martin
Journal:  Development       Date:  1995-02       Impact factor: 6.868

View more
  27 in total

1.  AcvR1-mediated BMP signaling in second heart field is required for arterial pole development: implications for myocardial differentiation and regional identity.

Authors:  Penny S Thomas; Sudha Rajderkar; Jamie Lane; Yuji Mishina; Vesa Kaartinen
Journal:  Dev Biol       Date:  2014-03-27       Impact factor: 3.582

Review 2.  The neural crest in cardiac congenital anomalies.

Authors:  Anna Keyte; Mary Redmond Hutson
Journal:  Differentiation       Date:  2012-05-15       Impact factor: 3.880

3.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

Review 4.  A new heart for a new head in vertebrate cardiopharyngeal evolution.

Authors:  Rui Diogo; Robert G Kelly; Lionel Christiaen; Michael Levine; Janine M Ziermann; Julia L Molnar; Drew M Noden; Eldad Tzahor
Journal:  Nature       Date:  2015-04-23       Impact factor: 49.962

5.  Bisphenol A Represses Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells through Downregulating the Expression of Insulin-like Growth Factor 1.

Authors:  Boxian Huang; Song Ning; Qinjing Zhang; Aiqin Chen; Chunyan Jiang; Yugui Cui; Jian Hu; Hong Li; Guoping Fan; Lianju Qin; Jiayin Liu
Journal:  Mol Neurobiol       Date:  2016-06-07       Impact factor: 5.590

6.  Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.

Authors:  Shuo-Chieh Wu; Loretta S Li; Nadja Kopp; Joan Montero; Bjoern Chapuy; Akinori Yoda; Amanda L Christie; Huiyun Liu; Alexandra Christodoulou; Diederik van Bodegom; Jordy van der Zwet; Jacob V Layer; Trevor Tivey; Andrew A Lane; Jeremy A Ryan; Samuel Y Ng; Daniel J DeAngelo; Richard M Stone; David Steensma; Martha Wadleigh; Marian Harris; Emeline Mandon; Nicolas Ebel; Rita Andraos; Vincent Romanet; Arno Dölemeyer; Dario Sterker; Michael Zender; Scott J Rodig; Masato Murakami; Francesco Hofmann; Frank Kuo; Michael J Eck; Lewis B Silverman; Stephen E Sallan; Anthony Letai; Fabienne Baffert; Eric Vangrevelinghe; Thomas Radimerski; Christoph Gaul; David M Weinstock
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

7.  Altered Tbx1 gene expression is associated with abnormal oesophageal development in the adriamycin mouse model of oesophageal atresia/tracheo-oesophageal fistula.

Authors:  Danielle Mc Laughlin; Paula Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2014-02       Impact factor: 1.827

8.  TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression.

Authors:  Xiaomeng Li; Xianhui Ruan; Peitao Zhang; Yang Yu; Ming Gao; Shukai Yuan; Zewei Zhao; Jie Yang; Li Zhao
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

9.  Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder.

Authors:  Ning Liu; Kelly Schoch; Xi Luo; Loren D M Pena; Venkata Hemanjani Bhavana; Mary K Kukolich; Sarah Stringer; Zöe Powis; Kelly Radtke; Cameron Mroske; Kristen L Deak; Marie T McDonald; Allyn McConkie-Rosell; M Louise Markert; Peter G Kranz; Nicholas Stong; Anna C Need; David Bick; Michelle D Amaral; Elizabeth A Worthey; Shawn Levy; Michael F Wangler; Hugo J Bellen; Vandana Shashi; Shinya Yamamoto
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

10.  To activate or not to activate: the existential dilemma of an enhancer.

Authors:  Cornelis J Boogerd; Sylvia M Evans
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.